Transamerica Axiom III review

It depends on what the buyer is looking for. For someone who wants a variable annuity with broad investment choice, a relatively competitive base cost, and a shorter surrender horizon, Axiom III is a reasonable option in its category. It is less appealing for someone who wants principal protection — variable annuities carry real market risk — or for someone who wants a simpler product with lower total cost of ownership.

The main reason to buy Axiom III is access to tax-deferred market growth through a wide range of institutional subaccounts inside a shorter-commitment variable annuity wrapper. The secondary reason is optionality. Buyers can start without a living benefit rider and add one later, or can elect a guaranteed minimum accumulation or withdrawal benefit at issue, depending on their planning horizon.

I think Axiom III is best for someone who is comfortable with market risk, wants more investment flexibility than a fixed or indexed annuity provides, and prefers the 5-year surrender schedule over the longer commitments common in income-focused variable annuities. It is less appealing for someone who primarily wants income guarantees from day one, someone who expects to need liquidity beyond the 10% free amount during the surrender period, or someone who finds variable annuity cost structures difficult to evaluate.

You are buying tax-deferred access to a diversified investment platform inside an insurance contract. Unlike a fixed or indexed annuity, contract value here can go down. The insurance wrapper provides tax deferral, optional death benefit enhancements, and optional living benefits — but it does not protect against subaccount losses. The real trade is flexibility and tax deferral in exchange for layered costs and the complexity of managing variable subaccount allocations over time.

The core of Axiom III is its investment platform. Buyers can allocate among 74 variable subaccounts covering equity, bond, balanced, sector, and managed-risk strategies from managers including BlackRock, Fidelity, American Funds, Vanguard, Goldman Sachs, J.P. Morgan, and others. The subaccount net expense ratios range from 0.13% for Vanguard index options to 1.59% for TA Goldman Sachs 70/30 VP, so the total cost to the buyer depends heavily on which subaccounts are chosen.

The contract also includes fixed account options at 0.25% with guarantee periods of one, three, five, and seven years, plus dollar-cost averaging accounts at 0.25% for six and twelve months and 2.00% for the thirteen-to-twenty-four month DCA option. These fixed options give conservative-leaning buyers a place to park premium while they phase into the variable subaccounts.

Up to 12 transfers per year are allowed at no charge. That makes ongoing rebalancing practical without triggering additional fees.

The optional living benefit riders are the most meaningful secondary feature here. Three riders are available on Axiom III as of available materials: the Transamerica Principal Optimizer Rider II in 10-year and 7-year waiting period versions, and the Transamerica Income Edge 1.2 Rider V.

The Principal Optimizer riders combine a Guaranteed Minimum Withdrawal Benefit with a Guaranteed Minimum Accumulation Benefit. The 10-year version guarantees the account value will be at least 110% of the benefit base at the end of the 10-year waiting period; the 7-year version guarantees 100% of the benefit base at seven years. Both riders charge 1.35% annually based on the greater of the withdrawal base or GMAB benefit base, and can step up annually if account value exceeds the benefit base. The maximum benefit charge can rise to 2.50%.

The Income Edge 1.2 Rider V is a GLWB without the GMAB feature. It charges 1.45% for single life or 1.55% for joint life, assessed quarterly against the withdrawal base. Withdrawal percentages are age-banded and increase meaningfully if income is deferred — from 5.00% at ages 59–64 for single life (in years one through four since last premium) up to 12.75% for single life at age 95+ if income is deferred eight or more years.

Riders require 25% of account value to be held in a Stable Account, with the remaining 75% subject to allocation guidelines. This investment restriction matters because it limits the buyer's ability to pursue aggressive equity growth while a rider is active.

Free withdrawals of up to 10% of total premiums paid are available immediately — not after the first year. That is a meaningful distinction compared to many variable annuities that restrict free withdrawals to year two and beyond. The surrender schedule runs 7%, 6%, 5%, 4%, 3%, 0% over five years based on the age of each premium payment, not the contract anniversary.

Nursing home and terminal illness waivers allow penalty-free surrender or withdrawal if the contract owner or spouse is confined to a hospital or nursing facility for 30 or more consecutive days, or is diagnosed with a terminal condition with less than one year to live. An unemployment waiver is also available in most states. These provisions provide meaningful flexibility in hardship situations.

Withdrawals from the fixed account may be subject to an excess interest adjustment. That is a separate mechanism from the surrender charge and applies specifically to early exits from the fixed crediting options.

The base annual expense is 1.00% — M&E of 0.85% plus administration of 0.15%. That is competitive for a B-share variable annuity. The annual service charge of up to $35 per year is waived at $100,000 or more, so most buyers at moderate contract values will not pay it.

The subaccount expenses layer on top of the base charge. A buyer in a Vanguard allocation option may see total investment-level costs well under 1.25%. A buyer in actively managed or specialty subaccounts could push well above 2.00% in combined fees before any rider is added. A fund facilitation fee of up to 0.60% applies to certain investment options.

Adding a living benefit rider stacks another 1.35% to 1.55% on top of those costs. Total annual charges for a rider-equipped contract can reasonably approach or exceed 3.00% depending on subaccount selection — which is a real drag on the growth needed to outpace that fee structure over time.

The death benefit in its base form is the greater of account value or cash surrender value. Optional enhanced death benefit riders — Annual Step-Up (0.35% annually) and Return of Premium (0.15% annually) — can improve the legacy story for buyers who want that protection.

Transamerica Axiom III is issued by Transamerica Life Insurance Company, based in Cedar Rapids, Iowa. Transamerica is part of Aegon, a multinational insurance group. As cited in available product materials, Transamerica Life Insurance Company carries an A.M. Best rating of A and a Standard and Poor's rating of A+. Transamerica is a large-scale annuity carrier with broad distribution through full-service broker-dealers, independent broker-dealers, and banks.